Free Trial

HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Bank of New York Mellon Corp

HCA Healthcare logo with Medical background

Bank of New York Mellon Corp lowered its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,257,884 shares of the company's stock after selling 25,484 shares during the quarter. Bank of New York Mellon Corp owned about 0.51% of HCA Healthcare worth $434,662,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Atwood & Palmer Inc. bought a new position in shares of HCA Healthcare during the 1st quarter worth about $28,000. Bartlett & CO. Wealth Management LLC raised its stake in shares of HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after buying an additional 80 shares during the last quarter. ORG Partners LLC raised its holdings in shares of HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after acquiring an additional 86 shares during the period. Tidemark LLC bought a new position in shares of HCA Healthcare in the 4th quarter valued at about $36,000. Finally, Legacy Investment Solutions LLC increased its holdings in shares of HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after purchasing an additional 95 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer directly owned 12,646 shares of the company's stock, valued at $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 1.30% of the company's stock.

HCA Healthcare Price Performance

Shares of HCA stock traded down $0.48 on Monday, reaching $376.11. The company's stock had a trading volume of 368,895 shares, compared to its average volume of 1,596,243. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07. The stock's fifty day simple moving average is $371.55 and its 200-day simple moving average is $339.67. The company has a market capitalization of $90.48 billion, a price-to-earnings ratio of 16.72, a price-to-earnings-growth ratio of 1.30 and a beta of 1.47. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The firm's quarterly revenue was up 5.7% on a year-over-year basis. During the same period in the prior year, the business earned $5.36 EPS. Analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were issued a $0.72 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.77%. HCA Healthcare's payout ratio is currently 12.81%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday. Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Barclays set a $416.00 target price on shares of HCA Healthcare and gave the company an "overweight" rating in a report on Monday, June 2nd. Morgan Stanley set a $410.00 price objective on shares of HCA Healthcare and gave the stock an "equal weight" rating in a report on Monday, June 9th. Finally, Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Seven research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $395.71.

Get Our Latest Report on HCA

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines